Top 5 Circulating Tumor Cells Companies 2022

Published Date : Nov 2022
Author : Poonam Gorade
Biography : Content Strategist specializing in SEO content, blog content, and social media. Extensive experience and expertise in market research based content curation

A cell which has shed into the vasculature or lymphatics from a primary tumor and is carried around the body in the blood circulation is nothing but the circulating tumor cell (CTC). These CTCs can extravasate and become seeds for the subsequent growth of additional tumor (metastases) in distant organs which is a mechanism that is responsible for the vast majority of cancer-related deaths. The detection and analysis of CTCs can assist early patient prospects and determine appropriate tailored treatments. There is one method for CTC detection which is FDA-approved is CellSearch that used for diagnosing colorectal,  breast and prostate cancer. The detection of CTCs or liquid biopsy has several advantages over traditional tissue biopsies such as they are non-invasive that can be used repeatedly and provide more useful information on metastatic risk,  treatment effectiveness and disease progression. This CTC enumeration is an accepted prognostic indicator for breast,  prostate,  and colorectal cancer.

The global demand for Circulating Tumor Cells market,  in terms of revenue,  was worth of USD 136.41 million in 2019 and is expected to reach USD 320.07 million in 2026,  growing at a CAGR of 13.43% from 2020 to 2026. The global Circulating Tumor Cells market is expected to grow at significant growth rate due to number of driving factor.

Growing Prevalence of Cancer and Increasing Advancements in Biomedical Imaging and Bioengineering Technology are Some of the Major Factors Driving the Market Growth

Circulating Tumor Cells Companies

Menarini Silicon Biosystems


Menarini Silicon Biosystems established in 2005 and headquartered in Bologna, Italy. Specialties in cell sorting, circulating tumor cells, stem cells, single cell analysis, resolving tumor heterogeneity, rare cell isolation, delivering precision, delivering 100% pure tumor cells from FFPE tissue samples, FFPE, and Forensics. Menarini Silicon Biosystems had 107 Employees and had a revenue of $ 21 Million.


Ikonisys established in 1999 and headquartered in New Haven, Connecticut, United States. Specialties in Rare Cell Detection, FISH-based  tests, the  rare  cell detection  and  analysis  capabilities  of  the  platform. Ikonisys had 28 Employees and had a revenue of $ 5 Million.

Miltenyi Biotec

Miltenyi Biotec established in 1989 and headquartered in Bergisch Gladbach, North Rhine-Westphalia Germany. Specialties in Immunology, Stem Cell Research, Cancer Research, Neuroscience, Cell Isolation, Cell Sorting, Sample Preparation, Tissue Dissociation, Cell Culture, Cytokines, Antibodies, Imaging Agents, Molecular Analysis, Clinical Applications, Basic Research, and Translational Research. Miltenyi Biotec had 3000 Employees and had a revenue of $ 752 Million.

Advanced Cell Diagnostics

Advanced Cell Diagnostics established in 2006 and headquartered at Newark, CA. Specialties in RNA ISH, RNAscope, RNA in situ hybridization, RNA biomarkers, Quantitative Molecular Detection, Morphological Context, Single Cell Analysis, RNA-Seq, Chromogenic in situ hybridization (CISH), Fluorescent in situ hybridization (FISH), splice variants, antibody validation , companion diagnostics , precision medicine , pathology, ISH, BaseScope, CDx, cancer, neuroscience, gene therapy, safety toxicology , target validation , and IHC. Advanced Cell Diagnostics (ACD) had 107 Employees and had a revenue of $ 7 Million.

AVIVA Biosciences

AVIVA Biosciences established in 1997 and headquartered at San Diego, CA. Specialties in Cardiac and vascular safety, Ion channels voltage clamp and electrophysiology, Ion channel clonal cell lines, Training and consulting services, Cell enrichment, Cell isolation, RBC removal, circulating rare cells, and Nucleated cell recovery. AVIVA had 25 Employees and had a revenue of $ 5 Million.

Key Benefits of Global Reusable Circulating Tumor Cells Market Report-

Global market report covers in depth historical and forecast analysis.

Global market research report provides detailed information about Market Introduction, Market Summary, Global Market Revenue (USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country level.

Global market report helps to identify opportunities in market place.

Global market report covers extensive analysis of emerging trends and competitive landscape.



We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us



BrandEssence® Market Research and Consulting Pvt ltd.

124, City Road, London EC1V 2NX




1-888-853-7040 - U.S. (TOLL FREE)+44-1173181773 - U.K. OFFICE+91-7447409162 - INDIA OFFICE

© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®